- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-17-0020065

About Agarwal Life Sciences Private Limited
Data last updated:
Agarwal Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 04 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2010PTC198446. Its GSTIN is 27AAICA7450P1Z3 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Manjudevi Ramakant Pilani and Akansha Ranju Pilani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 306 3rd Floor Wellington Business Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.97 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹1.52 Cr (net margin 3.2%) and EBITDA of ₹2.81 Cr (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 7% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Agarwal Life Sciences. As per MCA filings, the company has open charges of ₹4.76 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
Agarwal Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0020065). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website agarwallife.com.
Company details
Recognitions & Rankings of Agarwal Life Sciences
Contact details
Agarwal Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is agarwallife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address306 3rd Floor Wellington Business Park – II Marol Naka Andheri Kurla Road. Andheri, East, Mumbai, Maharashtra, India – 400059
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Agarwal Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Agarwal Life Sciences operates one associated brand: Agarwal Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures fine chemicals and APIs for pharmaceuticals and food fortification. | agarwallife.com |
Business activity
The main business activities of Agarwal Life Sciences are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Agarwal Life Sciences Private Limited, buy the company report.
Financials of Agarwal Life Sciences Private Limited
FY 2024 filings availableAgarwal Life Sciences Private Limited reported revenue of ₹46.97 Cr (down 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.81 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Agarwal Life Sciences Private Limited, buy the company report.
Board of directors of Agarwal Life Sciences Private Limited
Agarwal Life Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manjudevi Ramakant Pilani Also directs: Ganesh Organics Limited, Millennium Lifecare Limited, Gi Corporate Advisors Private Limited and 3 more | Director | 26 Jul 2023 | 3 Years 3 Months | Current |
| Akansha Ranju Pilani | Director | 04 Jan 2010 | 16 Years 10 Months | Current |
| Ranju Ramakant Pilani Also directs: Ganesh Organics Limited, Sun Bulkactives Private Limited, Millennium Lifecare Limited and 2 more | Director | 04 Jan 2010 | 16 Years 10 Months | Current |
Peer comparison
Agarwal Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (API Manufacturers, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pon Pure Speciality Chemical Private Limited | ₹47.35 Cr (FY 2025) | 112.0% | Chennai, Tamil Nadu, India | |||
| Taurus Chemicals Pvt Ltd | ₹47.32 Cr (FY 2025) | 10.0% | Hyderabad, Telangana, India | |||
| Agarwal Life Sciences Private Limitedthis company | ₹46.97 Cr (FY 2025) | ₹1.52 Cr | 3.2% | -18.0% | 24 | Mumbai, Maharashtra, India |
| PSN Medicare Private Limited | ₹46.96 Cr (FY 2025) | -48.0% | Hyderabad, Telangana, India | |||
| Heptachem & Pharma (India) Private Limited | ₹46.48 Cr (FY 2024) | -18.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Agarwal Life Sciences Private Limited, buy the company report.
Auditor
Agarwal Life Sciences Private Limited is audited by SOURABHMAHESHAGRAWAL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SOURABHMAHESHAGRAWAL | FY 2023 | 112001 |
Shareholding
The shareholding of Agarwal Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Agarwal Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 May 2012 | 10382095 | Others | ₹4.76 Cr | Open |
To see the full charge records of Agarwal Life Sciences Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Agarwal Life Sciences Private Limited has 3 court cases on record: 3 filed by Agarwal Life Sciences. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against Standard Pharmaceuticals Ltd and 4 others | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed by the company against Kothari Pharma Industries. Prop. Amit Kothari. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed by the company against an individual | Pending |
To see the full case history of Agarwal Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Agarwal Life Sciences Private Limited was last rated by Indiarating on 30 Apr 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Indiarating | 30 Apr 2021 |
To see the full credit ratings and regulatory alerts of Agarwal Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Agarwal Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Agarwal Life Sciences Private Limited has a workforce of 24 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 24 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2015-16 | |
| FY 2014-15 | |
| FY 2013-14 | |
| FY 2012-13 |
To see the full employee and EPFO history of Agarwal Life Sciences Private Limited, buy the company report.
GST
Agarwal Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICA7450P1Z3 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Agarwal Life Sciences Private Limited, buy the company report.
Recent activity
Agarwal Life Sciences Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Manjudevi Ramakant Pilani ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Agarwal Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 04 January 2010 (16+ years old) and is registered under CIN U24100MH2010PTC198446.
Agarwal Life Sciences has 3 current directors:
- Manjudevi Ramakant Pilani - Director
- Akansha Ranju Pilani - Director
- Ranju Ramakant Pilani - Director
The latest financial statements of Agarwal Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Agarwal Life Sciences is 27AAICA7450P1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Agarwal Life Sciences is U24100MH2010PTC198446. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Agarwal Life Sciences has 3 court cases on record: 3 filed by the company. 3 are pending.
Agarwal Life Sciences was incorporated on 04 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Agarwal Life Sciences by revenue are Pon Pure Speciality Chemical Private Limited, Taurus Chemicals Pvt Ltd, PSN Medicare Private Limited, Heptachem & Pharma (India) Private Limited, all in the Chemicals industry (API Manufacturers, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manjudevi Ramakant Pilani ceased to be Additional Director on 29 Sep 2024. Manjudevi Ramakant Pilani was appointed as Director on 26 Jul 2023. Akansha Ranju Pilani was appointed as Director on 04 Jan 2010. Agarwal Life Sciences has 4 board changes on record in total.
Yes, Agarwal Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-17-0020065).
Agarwal Life Sciences can be reached through the website agarwallife.com. Its registered office is in Mumbai, Maharashtra, India.

